메뉴 건너뛰기




Volumn 17, Issue 9, 2004, Pages 495-504

The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy

Author keywords

Cyclosporine; Pharmacokinetics; Side effects; Solid organ transplantation; Therapeutic drug monitoring; Toxicity

Indexed keywords

CYCLOSPORIN;

EID: 9944233615     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.tb00478.x     Document Type: Article
Times cited : (5)

References (29)
  • 1
    • 0024976004 scopus 로고
    • Cyclosporine
    • Kahan BD. Cyclosporine. N Engl J Med 1989; 321:1725
    • (1989) N Engl J Med , vol.321 , pp. 1725
    • Kahan, B.D.1
  • 2
    • 0027226147 scopus 로고
    • Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation
    • Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993; 54:205
    • (1993) Clin Pharmacol Ther , vol.54 , pp. 205
    • Lindholm, A.1    Kahan, B.D.2
  • 3
    • 0036580336 scopus 로고    scopus 로고
    • How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients
    • Klupp J, Holt DW, van Gelder T. How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients. Transpl Immunol 2002; 9:211
    • (2002) Transpl Immunol , vol.9 , pp. 211
    • Klupp, J.1    Holt, D.W.2    Van Gelder, T.3
  • 4
    • 0028909913 scopus 로고
    • Cyclosporine trough levels, acute rejection, and renal dysfunction after heart transplantation
    • Cantarovich M, Fitchett D, Latter DA. Cyclosporine trough levels, acute rejection, and renal dysfunction after heart transplantation. Transplantation 1995; 59:444
    • (1995) Transplantation , vol.59 , pp. 444
    • Cantarovich, M.1    Fitchett, D.2    Latter, D.A.3
  • 5
    • 0033565808 scopus 로고    scopus 로고
    • Neoral monitoring by simplified sparse sampling area under the concentration-time curve: Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation
    • Mahalati K, Belitsky P, Sketris I, West K, Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999; 68:55
    • (1999) Transplantation , vol.68 , pp. 55
    • Mahalati, K.1    Belitsky, P.2    Sketris, I.3    West, K.4    Panek, R.5
  • 6
    • 0036766650 scopus 로고    scopus 로고
    • Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: Patients monitored by absorption profiling
    • Clase CM, Mahalati K, Kiberd BA, Lawen JG, West KA, Fraser AD, et al. Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling. Am J Transplant 2002; 2:789
    • (2002) Am J Transplant , vol.2 , pp. 789
    • Clase, C.M.1    Mahalati, K.2    Kiberd, B.A.3    Lawen, J.G.4    West, K.A.5    Fraser, A.D.6
  • 8
    • 0034192312 scopus 로고    scopus 로고
    • Pharmacokinetic validation of Neoral absorption profiling
    • Johnston A, David OJ, Cooney GF. Pharmacokinetic validation of Neoral absorption profiling. Transplant Proc 2000; 32:53S
    • (2000) Transplant Proc , vol.32
    • Johnston, A.1    David, O.J.2    Cooney, G.F.3
  • 9
    • 0034743294 scopus 로고    scopus 로고
    • C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation
    • Levy GA. C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation. BioDrugs 2001; 15:279
    • (2001) BioDrugs , vol.15 , pp. 279
    • Levy, G.A.1
  • 10
    • 0035086066 scopus 로고    scopus 로고
    • Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study
    • Mahalati K, Belitsky P, West K, Kiberd B, Fraser A, Sketris I, et al. Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J Am Soc Nephrol 2001; 12:828
    • (2001) J Am Soc Nephrol , vol.12 , pp. 828
    • Mahalati, K.1    Belitsky, P.2    West, K.3    Kiberd, B.4    Fraser, A.5    Sketris, I.6
  • 11
    • 0037093525 scopus 로고    scopus 로고
    • Patient management by Neoral C(2) monitoring: An international consensus statement
    • Levy G, Thervet E, Lake J, Uchida K. Patient management by Neoral C(2) monitoring: an international consensus statement. Transplantation 2002; 73:812
    • (2002) Transplantation , vol.73 , pp. 812
    • Levy, G.1    Thervet, E.2    Lake, J.3    Uchida, K.4
  • 12
    • 0037181448 scopus 로고    scopus 로고
    • Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)
    • Levy G, Burra P, Cavallari A, Duvoux C, Lake J, Mayer AD, et al. Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation 2002; 73:953
    • (2002) Transplantation , vol.73 , pp. 953
    • Levy, G.1    Burra, P.2    Cavallari, A.3    Duvoux, C.4    Lake, J.5    Mayer, A.D.6
  • 13
    • 0012007095 scopus 로고    scopus 로고
    • Monitoring of 2-hour Neoral absorption in renal transplantation (MO2ART): Interim analysis shows low incidence of acute rejection in the early post-graft period
    • The MO2ART study group. Abstract no. 1037.
    • Pfeffer P, Stefoni S, Agost Carreno C, Thervet E, Fornairon S, Keown P. Monitoring of 2-hour Neoral absorption in renal transplantation (MO2ART): interim analysis shows low incidence of acute rejection in the early post-graft period. The MO2ART study group. Abstract no. 1037. Am J Transplant 2002; 2:399
    • (2002) Am J Transplant , vol.2 , pp. 399
    • Pfeffer, P.1    Stefoni, S.2    Agost Carreno, C.3    Thervet, E.4    Fornairon, S.5    Keown, P.6
  • 14
    • 0009944063 scopus 로고    scopus 로고
    • Excellent renal tolerability of Neoral C-2 h monitoring in the de novo kidney transplantation: Initial results of the MO2ART trial
    • The MO2ART study group. Abstract no. 1038
    • Buchler M, Chadban S, Jost L, Rodriguez A, Beauregard L, Balshaw R. Excellent renal tolerability of Neoral C-2 h monitoring in the de novo kidney transplantation: initial results of the MO2ART trial. The MO2ART study group. Abstract no. 1038. Am J Transplant 2002; 2:399
    • (2002) Am J Transplant , vol.2 , pp. 399
    • Buchler, M.1    Chadban, S.2    Jost, L.3    Rodriguez, A.4    Beauregard, L.5    Balshaw, R.6
  • 15
    • 0033611084 scopus 로고    scopus 로고
    • Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients
    • Cantarovich M, Elstein E, de Varennes B, Barkun JS. Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 1999; 68:1839
    • (1999) Transplantation , vol.68 , pp. 1839
    • Cantarovich, M.1    Elstein, E.2    De Varennes, B.3    Barkun, J.S.4
  • 16
    • 0037093506 scopus 로고    scopus 로고
    • Clinical validation studies of Neoral C(2) monitoring: A review
    • Nashan B, Cole E, Levy G, Thervet E. Clinical validation studies of Neoral C(2) monitoring: a review. Transplantation 2002; 73:S3
    • (2002) Transplantation , vol.73
    • Nashan, B.1    Cole, E.2    Levy, G.3    Thervet, E.4
  • 17
    • 0037006627 scopus 로고    scopus 로고
    • Efficacy and safety of tacrolimus compared with cyclosporin micro-emulsion in renal transplantation: A randomised multicentre study
    • Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporin micro-emulsion in renal transplantation: a randomised multicentre study. Lancet 2002; 359:741
    • (2002) Lancet , vol.359 , pp. 741
    • Margreiter, R.1
  • 18
    • 0037068958 scopus 로고    scopus 로고
    • Tacrolimus versus micro-emulsified cyclosporin in liver transplantation: The TMC randomised controlled trial
    • O'Grady JG, Burroughs A, Hardy P, Elbourne D, Truesdale A. Tacrolimus versus micro-emulsified cyclosporin in liver transplantation: the TMC randomised controlled trial. Lancet 2002; 360:1119
    • (2002) Lancet , vol.360 , pp. 1119
    • O'Grady, J.G.1    Burroughs, A.2    Hardy, P.3    Elbourne, D.4    Truesdale, A.5
  • 20
    • 0029028666 scopus 로고
    • Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients
    • Batiuk TD, Pazderka F, Halloran PF. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation 1995; 59:1400
    • (1995) Transplantation , vol.59 , pp. 1400
    • Batiuk, T.D.1    Pazderka, F.2    Halloran, P.F.3
  • 22
    • 0033571210 scopus 로고    scopus 로고
    • The temporal profile of calcineurin inhibition by cyclosporine in vivo
    • Halloran PF, Helms LM, Kung L, Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999; 68:1356
    • (1999) Transplantation , vol.68 , pp. 1356
    • Halloran, P.F.1    Helms, L.M.2    Kung, L.3    Noujaim, J.4
  • 23
    • 0037852297 scopus 로고    scopus 로고
    • Long term follow up of maintenance patients converted to C2 cyclosporine using Neoral immunosuppression
    • Abstract no. 925
    • Levy G, Smith R, O'Grady C, Lilly LB, Girgah N, Greig PD, Grant DR. Long term follow up of maintenance patients converted to C2 cyclosporine using Neoral immunosuppression. Abstract no. 925. Am J Transplant 2002; 2:370
    • (2002) Am J Transplant , vol.2 , pp. 370
    • Levy, G.1    Smith, R.2    O'Grady, C.3    Lilly, L.B.4    Girgah, N.5    Greig, P.D.6    Grant, D.R.7
  • 24
    • 0037774756 scopus 로고    scopus 로고
    • Clinical benefits of Neoral C2 monitoring in the long-term management of renal transplant recipients
    • Cole E, Maham N, Cardella C, Cattran D, Fenton S, Hamel J, et al. Clinical benefits of Neoral C2 monitoring in the long-term management of renal transplant recipients. Transplantation 2003; 75:2086
    • (2003) Transplantation , vol.75 , pp. 2086
    • Cole, E.1    Maham, N.2    Cardella, C.3    Cattran, D.4    Fenton, S.5    Hamel, J.6
  • 25
    • 0034908479 scopus 로고    scopus 로고
    • Conversion from cyclosporin a to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression
    • Baan CC, van Riemsdijk-van Overbeeke IC, Balk AH, Vantrimpont PM, Mol WM, Knoop CJ, et al. Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression. Clin Transplant 2001; 15:276
    • (2001) Clin Transplant , vol.15 , pp. 276
    • Baan, C.C.1    Van Riemsdijk-van Overbeeke, I.C.2    Balk, A.H.3    Vantrimpont, P.M.4    Mol, W.M.5    Knoop, C.J.6
  • 26
    • 0034719672 scopus 로고    scopus 로고
    • The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol
    • Thorp M, DeMattos A, Bennett W, Barry J, Norman D. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. Transplantation 2000; 69:1218
    • (2000) Transplantation , vol.69 , pp. 1218
    • Thorp, M.1    DeMattos, A.2    Bennett, W.3    Barry, J.4    Norman, D.5
  • 27
    • 0031804665 scopus 로고    scopus 로고
    • Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus
    • Friemann S, Feuring E, Padberg W, Ernst W. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Transplant Proc 1998; 30:1240
    • (1998) Transplant Proc , vol.30 , pp. 1240
    • Friemann, S.1    Feuring, E.2    Padberg, W.3    Ernst, W.4
  • 28
    • 0035959923 scopus 로고    scopus 로고
    • Conversion from cyclosporine to FK506 in adult liver transplant recipients: A combined North American and European experience
    • Selzner N, Durand F, Bernuau J, Heneghan MA, Tuttle-Newhall JE, Belghiti J, et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. Transplantation 2001; 72:1061
    • (2001) Transplantation , vol.72 , pp. 1061
    • Selzner, N.1    Durand, F.2    Bernuau, J.3    Heneghan, M.A.4    Tuttle-Newhall, J.E.5    Belghiti, J.6
  • 29
    • 0033774719 scopus 로고    scopus 로고
    • A meta-analysis of immunosuppression withdrawal trials in renal transplantation
    • Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11:1910
    • (2000) J Am Soc Nephrol , vol.11 , pp. 1910
    • Kasiske, B.L.1    Chakkera, H.A.2    Louis, T.A.3    Ma, J.Z.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.